[CAS NO. 522629-08-9]  CGP 57380

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [522629-08-9]

Catalog
HY-10520
Brand
MCE
CAS
522629-08-9

DESCRIPTION [522629-08-9]

Overview

MDLMFCD03861062
Molecular Weight244.23
Molecular FormulaC11H9FN6
SMILESNC1=NC=NC2=C1C(NC3=CC=C(F)C=C3)N=N2

For research use only. We do not sell to patients.


Summary

CGP 57380 is a cell-permeable pyrazolo-pyrimidine compound that acts as a selective inhibitor of Mnk1 with IC 50 of 2.2 μM, but has no inhibitory activity against p38, JNK1 , ERK1/2, PKC , or Src-like kinases.


IC50 & Target

MNK1

2.2 μM (IC 50 )


In Vitro

CGP57380 inhibits phosphorylation of eIF4E in cellular assays with IC 50 of about 3 μM. CGP57380 causes dephosphorylation of eIF4E, and induces a further increase in the cap-dependent reporter in 293 cells [1] . CGP57380 results in dose-dependent decreases in Ang II-stimulated phosphorylation of eIF4E, protein synthesis, and VSMC hypertrophy [2] . CGP57380 sensitizes wild-type cells for serum-withdrawal induced apoptosis in mouse embryo fibroblasts (MEFs) [3] . CGP57380 prevents the serial replating function of BC progenitors [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

CGP57380 (40 mg/kg/d i.p.) potently extinguishes the ability of BC CML cells to serially transplant-immunodeficient mice and function as LSCs [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 6 mg/mL ( 24.57 mM ; Need ultrasonic and warming)

H 2 O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.0945 mL 20.4725 mL 40.9450 mL
5 mM 0.8189 mL 4.0945 mL 8.1890 mL
10 mM 0.4095 mL 2.0473 mL 4.0945 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (10.24 mM); Clear solution

* All of the co-solvents are available by MCE.